Search research articles
Contact Us
Filters
Showing results (41-50 of 194) with videos related to
Page
of 20
Sort By:
Therapeutics and Clinical Risk Management
|
June 6, 2015
New developments in the management of severe skin and deep skin structure infections - focus on tedizolid
Michael J Durkin, G Ralph Corey
The American Journal of Medicine
|
March 11, 2009
Staphylococcus aureus bacteremia among patients with health care-associated fever
Martin E Stryjewski, Zeina A Kanafani, Vivian H Chu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 28, 2008
Epidemiology of methicillin-resistant Staphylococcus aureus
Helen W Boucher, G Ralph Corey
Expert Review of Anti-Infective Therapy
|
April 4, 2007
Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections
Zeina A Kanafani, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2012
Ceftaroline applications for therapy in the United States
G Ralph Corey, Ronald N Jones
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 19, 2006
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia
Martin E Stryjewski, Lynda A Szczech, Daniel K Benjamin, et al.
Infection Control and Hospital Epidemiology
|
July 16, 2005
Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis
John J Engemann, Joelle Y Friedman, Shelby D Reed, et al.
Annals of Internal Medicine
|
March 22, 2006
Telithromycin
Michelle Turner, G Ralph Corey, Elias Abrutyn
The New England Journal of Medicine
|
September 23, 2014
Dalbavancin or oritavancin for skin infections
G Ralph Corey, Hai Jiang, Greg Moeck
Antimicrobial Agents and Chemotherapy
|
February 24, 2006
Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study
Martin E Stryjewski, Vivian H Chu, William D O'Riordan, et al.
Page
of 20
Search research articles
Search
Showing results (41-50 of 194) with videos related to
Sort By:
Page
of 20
Therapeutics and Clinical Risk Management
|
June 6, 2015
New developments in the management of severe skin and deep skin structure infections - focus on tedizolid
Michael J Durkin, G Ralph Corey
The American Journal of Medicine
|
March 11, 2009
Staphylococcus aureus bacteremia among patients with health care-associated fever
Martin E Stryjewski, Zeina A Kanafani, Vivian H Chu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 28, 2008
Epidemiology of methicillin-resistant Staphylococcus aureus
Helen W Boucher, G Ralph Corey
Expert Review of Anti-Infective Therapy
|
April 4, 2007
Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections
Zeina A Kanafani, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2012
Ceftaroline applications for therapy in the United States
G Ralph Corey, Ronald N Jones
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 19, 2006
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia
Martin E Stryjewski, Lynda A Szczech, Daniel K Benjamin, et al.
Infection Control and Hospital Epidemiology
|
July 16, 2005
Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis
John J Engemann, Joelle Y Friedman, Shelby D Reed, et al.
Annals of Internal Medicine
|
March 22, 2006
Telithromycin
Michelle Turner, G Ralph Corey, Elias Abrutyn
The New England Journal of Medicine
|
September 23, 2014
Dalbavancin or oritavancin for skin infections
G Ralph Corey, Hai Jiang, Greg Moeck
Antimicrobial Agents and Chemotherapy
|
February 24, 2006
Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study
Martin E Stryjewski, Vivian H Chu, William D O'Riordan, et al.
Page
of 20